Long-term grey matter structural changes in the transition from chronic migraine to episodic migraine
|Long-term grey matter structural changes in the transition from chronic migraine to episodic migraine
|Year of Publication
|Planchuelo-Gómez, Á., G. Marchante-Reíllo, Á. Sierra, D. García-Azorín, C. Martín-Martín, R. de Luis-García, S. Aja-Fernández, R. Moro, M. Rodríguez, Y. González-Osorio, and Á. L. Guerrero
|8th Congress of the European Academy of Neurology
Background and aims: The objective was to assess grey matter longitudinal changes in patients with chronic migraine (CM) who reverse to episodic migraine (EM) compared to those who do not reverse.
Methods: High-resolution 3D brain T1-weighted Magnetic Resonance Imaging data were obtained twice from migraine patients. The first acquisition was performed immediately after the first visit to the Headache Unit, before taking preventive treatments. The second timepoint was at least three years after the first acquisition. From the longitudinal pipeline of FreeSurfer (v6.0), the mean values of cortical thickness, surface area and grey matter volume of 68 cortical, 14 subcortical regions and the cerebellum were extracted. Longitudinal changes between patients with CM and those who reversed to EM were assessed with linear
Results: 22 patients were included, and 10 of them (45.5%) reversed to EM. No statistically significant differences of age (42.0+-9.0 years) and sex (21 women, 95.5%) were found between patient groups. Higher statistically significant values of the three parameters in patients who reversed to EM were found in the pericalcarine, parietal, orbitofrontal cortex, and amygdala (Table 1, Figure 1). In contrast, lower values were detected in the cingulum, caudal middle frontal cortex, cerebellum, caudate nucleus and pallidum (Figure 2). In the insula, higher thickness but lower area was appreciated in patients who reversed.
Conclusion: Patients with CM who reverse to EM present distinct patterns of increased and decreased morphometric parameters propagated in the orbital frontal cortex and the cingulum, respectively.
Disclosure: Nothing to disclose.